Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 228

The DOI matches its OpenAlex record; 1 of the 1 references it cites were found in a registry or an index.

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

Open access
Catherine B. Renard, Farah Kramer, Fredrik Johansson, Najib Lamharzi, Lisa R. Tannock, Matthias G. von Herrath, Alan Chait, Karin Bornfeldt·2004·Journal of Clinical Investigation

Abstract

Diabetes in humans accelerates cardiovascular disease caused by atherosclerosis. The relative contributions of hyperglycemia and dyslipidemia to atherosclerosis in patients with diabetes are not clear, largely because there is a lack of suitable animal models. We therefore have developed a transgenic mouse model that closely mimics atherosclerosis in humans with type 1 diabetes by breeding low-density lipoprotein receptor-deficient mice with transgenic mice in which type 1 diabetes can be induced at will. These mice express a viral protein under control of the insulin promoter and, when infected by the virus, develop an autoimmune attack on the insulin-producing beta cells and subsequently develop type 1 diabetes. When these mice are fed a cholesterol-free diet, diabetes, in the absence of associated lipid abnormalities, causes both accelerated lesion initiation and increased arterial macrophage accumulation. When diabetic mice are fed cholesterol-rich diets, on the other hand, they develop severe hypertriglyceridemia and advanced lesions, characterized by extensive intralesional hemorrhage. This progression to advanced lesions is largely dependent on diabetes-induced dyslipidemia, because hyperlipidemic diabetic and nondiabetic mice with similar plasma cholesterol levels show a similar extent of atherosclerosis. Thus, diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1172/jci17867

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 39

  1. 10.1001/jama.241.19.2035 · DOI · Paper page
  2. 10.1016/0092-8674(91)90165-U · DOI · Paper page
  3. 10.1016/0092-8674(91)90164-T · DOI · Paper page
  4. 10.1016/1074-7613(94)90101-5 · DOI · Paper page
  5. 10.1172/JCI117179 · DOI · Paper page
  6. Pichler, 2003, J. Am. Soc. Nephrol., 14, 124A
  7. 10.1172/JCI118604 · DOI · Paper page
  8. 10.1038/2012 · DOI · Paper page
  9. 10.2337/diabetes.49.6.1064 · DOI
  10. 10.2337/diabetes.50.7.1654 · DOI · Paper page
  11. Dixon, 1999, Arterioscler. Thromb. Vasc. Biol., 19, 2981, 10.1161/01.ATV.19.12.2981 · DOI
  12. Reaven, 1997, Arterioscler. Thromb. Vasc. Biol., 17, 2250, 10.1161/01.ATV.17.10.2250 · DOI
  13. 10.1161/01.CIR.0000124061.78478.94 · DOI · Paper page
  14. Williams, 1998, Curr. Opin. Lipidol., 9, 471, 10.1097/00041433-199810000-00012 · DOI · Paper page
  15. Cuff, 2001, J. Clin. Invest., 108, 1031, 10.1172/JCI200112455 · doi:10.1172/jci200112455 · Paper page
  16. Horiuchi, 1996, Diabetes., 45(Suppl. 3), S73, 10.2337/diab.45.3.S73 · DOI
  17. 10.1074/jbc.M006545200 · DOI · Paper page
  18. Januszewski, 2003, Biochem. Soc. Trans., 31, 1413, 10.1042/bst0311413 · DOI
  19. Kislinger, 2001, Arterioscler. Thromb. Vasc. Biol., 21, 905, 10.1161/01.ATV.21.6.905 · DOI · Paper page
  20. 10.2337/diabetes.51.5.1556 · DOI
  21. Virmani, 2000, Arterioscler. Thromb. Vasc. Biol., 20, 1262, 10.1161/01.ATV.20.5.1262 · DOI · Paper page
  22. Rosenfeld, 2000, Arterioscler. Thromb. Vasc. Biol., 20, 2587, 10.1161/01.ATV.20.12.2587 · DOI · Paper page
  23. 10.1161/01.ATV.0000014587.66321.B4 · DOI · Paper page
  24. 10.1161/01.ATV.0000060200.73623.F8 · DOI
  25. 10.2741/1190 · DOI
  26. 10.1016/S0002-8703(98)70144-9 · DOI
  27. 10.1056/NEJMoa035655 · DOI · Paper page
  28. 10.1016/S0021-9150(99)00479-7 · DOI · Paper page
  29. Moreno, 2000, Circulation., 102, 2180, 10.1161/01.CIR.102.18.2180 · DOI · Paper page
  30. 10.2337/diacare.14.9.839 · DOI · Paper page
  31. 10.2165/00003495-200060050-00001 · DOI
  32. Merat, 1999, Arterioscler. Thromb. Vasc. Biol., 19, 1223, 10.1161/01.ATV.19.5.1223 · DOI · Paper page
  33. Garber, 2000, J. Lipid Res., 41, 1020, 10.1016/S0022-2275(20)32045-9 · DOI
  34. Crawford, 1998, Arterioscler. Thromb. Vasc. Biol., 18, 1506, 10.1161/01.ATV.18.9.1506 · DOI
  35. Arnqvist, 1987, Clin. Chem., 33, 93, 10.1093/clinchem/33.1.93 · DOI
  36. Movat, 1955, Arch. Pathol., 60, 289
  37. 10.1021/bi00034a021 · DOI · Paper page
  38. 10.1007/s00125-003-1247-9 · DOI
  39. 10.2337/diabetes.50.4.851 · DOI · Paper page

Cited by

See all 228

Metadata

Authors
Renard, C. B., Kramer, F., Johansson, F., Lamharzi, N., Tannock, L. R., von Herrath, M. G., Chait, A., & Bornfeldt, K.
Venue
Journal of Clinical Investigation
Published
2004-09-01
Volume
114
Issue
5
Pages
659-668
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2082913643
Cited by
228
References
1
FWCI
4.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. https://app.cochat.ai/papers/10.1172/jci17867
The paper
Renard, C. B., Kramer, F., Johansson, F., Lamharzi, N., Tannock, L. R., von Herrath, M. G., Chait, A., & Bornfeldt, K. (2004). Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. Journal of Clinical Investigation. https://doi.org/10.1172/jci17867

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.